top of page

SF Healthcare Week: A buy side perspective of biotech with Affinity's Patrick Nosker

Patrick Nosker gives his take on today's conference news and highlights the science behind some of his firm's top holdings like Apogee, Teva, CymaBay, and Madrigal.




Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page